Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil

Pharmaceutical Research

Volumn 20, Issue 6, 2003, Pages 931-936

  Kast, Constantia E ^a   Guggi, Davide ^a   Langoth, Nina ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bioavailability; Heparin; Oral drug delivery system; Reduced glutathione; Thiomer

Indexed keywords

CYSTEINE; GLUTATHIONE; LOW MOLECULAR WEIGHT HEPARIN; POLYCARBOPHIL; THIOL DERIVATIVE;

ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG EFFECT; DRUG PENETRATION; DRUG UPTAKE; ENTERIC COATED TABLET; GUINEA PIG; INTESTINE MUCOSA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE;

ACRYLIC RESINS; ADMINISTRATION, ORAL; ALGORITHMS; ANIMALS; AREA UNDER CURVE; DRUG DELIVERY SYSTEMS; EXCIPIENTS; GLUTATHIONE; HEPARIN, LOW-MOLECULAR-WEIGHT; INTESTINAL ABSORPTION; INTESTINE, SMALL; PERMEABILITY; RATS; TABLETS;

EID: 0038015493     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023803706746     Document Type: Article

References (25)

1. J. Hirsh, T. E. Warkentin, R. Raschke, C. Granger, E. M. Ohman, and J. E. Dalen. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 114:489-510 (1998).
2. J. K. Thompson-Ford. Low-molecular-weight-heparin for the treatment of deep vein thrombosis. Pharmacotherapy 18:748-758 (1998).
3. Y. Lee, S. H. Kim, and Y. Byun. Oral delivery of new heparin derivatives in rats. Pharm. Res. 17:1259-1264 (2000).
4. Y. Jiao, N. Ubrich, M. Marchand-Arvier, C. Vigneron, M. Hoffman, T. Lecompte, and P. Maincent. In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits. Circulation 105:230-235 (2002).
5. A. Leone-Bay, D. R. Paton, J. Freeman, C. Lercara, D. O'Toole, D. Gschneidner, E. Wang, E. Harris, C. Rosado, T. Rivera, A. DeVincent, M. Tai, F. Mercogliano, R. Agarwal, H. Leipold, and R. A. Baughman. Synthesis and evaluation of compounds that facilitate the gastrointestinal absorption of heparin. J. Med. Chem. 41:1163-1171 (1998).
6. A. K. Morton, H. E. Edwards, J. C. Allen, and G. O. Phillips. An evaluation of the oral administration of commercial and fractionated heparin samples in rats. Int. J. Pharm. 9:321-335 (1981).
7. M. Ueno, T. Nakasaki, I. Horikoshi, and N. Sakuragawa. Oral administration of liposomally-entrapped heparin to beagle dogs. Chem. Pharm. Bull. 30:2245-2247 (1982).
8. B. J. Aungst, H. Saitoh, D. L. Burcham, S. M. Huang, S. A. Mousa, and M. A. Hussain. Enhancement of the intestinal absorption of peptides and non-peptides. J. Control. Release 41:19-31 (1996).
9. A. Bernkop-Schnürch, V. Schwarz, and S. Steininger. Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm. Res. 16:876-881 (1999).
10. A. Bernkop-Schnürch and S. Steininger. Synthesis and characterization of mucoadhesive thiolated polymers. Int. J. Pharm. 194: 239-247 (2000).
11. A. E. Clausen and A. Bernkop-Schnürch. In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil. J. Pharm. Sci. 89:1253-1261 (2000).
12. A. E. Clausen and A. Bernkop-Schnürch. Thiolated carboxymethylcellulose: in vitro evaluation of its permeation enhancing effect on peptide drugs. Eur. J. Pharm. Biopharm. 51:25-32 (2001).
13. C. E. Kast and A. Bernkop-Schnürch. Influence of the molecular mass on the permeation enhancing effect of different poly(acrylates). STP Pharm. 12:351-356 (2002).
14. M. K. Marschütz, P. Caliceti, and A. Bernkop-Schnürch. Design and in vivo evaluation of an oral delivery system for insulin. Pharm. Res. 17:1468-1474 (2000).
15. K. Yoshimura, Y. Iwauchi, S. Sugiyama, T. Kuwamura, Y. Odaka, T. Satoh, and H. Kitagawa. Transport of L-cysteine and reduced glutathione through biological membranes. Res. Commun. Chem. Pathol. Pharmacol. 37:171-186 (1982).
16. A. E. Clausen, C. E. Kast, and A. Bernkop-Schnürch. The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharm. Res. 19:602-608 (2002).
17. N. Blumenkrantz and G. Asboe-Hansen. New method for quantitative determination of uronic acids. Anal. Chem. 54:484-489 (1973).
18. S. R. Money and J. W. York. Development of oral heparin therapy for prophylaxis and treatment of deep venous thrombosis. Cardiovasc. Surg. 9:211-218 (2001).
19. B. J. Aungst. Intestinal permeation enhancers. J. Pharm. Sci. 89: 429-442 (2000).
20. M. D. Gonze, J. D. Manord, A. Leone-Bay, R. A. Baughman, and C. L. Garrard. W. C. III Sternberg, and S. R. Money. Orally administered heparin for preventing deep venous thrombosis. Am. J. Surg. 176:176-178 (1998).
21. K. Salartash, M. D. Gonze, A. Leone-Bay, and R. A. Baughman. W. C. III Sternberg, and S. R. Money. Oral low-molecular weight heparin and delivery agent prevents jugular venous thrombosis in the rat. J. Vasc. Surg. 30:526-532 (1999).
22. 14C-labelled poly(acrylic acids): an in vivo study. Biomaterials 22:1861-1867 (2001).
23. T. Iantomasi, F. Favilli, P. Marraccini, T. Magaldi, P. Bruni, and M. T. Vincenzini. Glutathione transport system in human small intestine epithelial cells. Biochim. Biophys. Acta 1330:274-283 (1997).
24. T. Rivera, A. Leone-Bay, D. R. Paton, H. Leipold. and R. A. Baughman. Oral delivery of heparin in combination with N-[8-(2-hydroxybenzoyl)amino]caprylate: pharmacological considerations. Pharm. Res. 14:1830-1834 (1997).
25. R. A. Baughman, S. C. Kapoor, R. Agarwal, J. Kisicki, F. Catella-Lawson, and G. A. FitzGerald. Oral delivery of anticoagulant doses of heparin. A randomized, double blind, controlled study in humans. Circulation 98:1610-1615 (1998).